NST-628 is an experimental oral small-molecule molecular glue from Nested Therapeutics, in phase 1 trials for MAPK pathway-mutated or -dependent advanced solid tumours, melanoma and non-small cell lung cancer and other cancers.
NST-628 is an oral small-molecule molecular glue from Nested Therapeutics. A non-degrading, fully brain-penetrant pan-RAF/MEK molecular glue that holds RAF and MEK (MEK1/2) together, hitting several parts of the RAS/MAPK pathway at once. Its furthest stage is phase 1, for MAPK pathway-mutated or -dependent advanced solid tumours, melanoma, non-small cell lung cancer and glioma. ClinicalTrials.gov registers it in 2 studies linked below. Phase 1 NCT06326411 recruiting; an investigator-sponsored early phase 1 in recurrent grade 4 glioma (NCT07784985, Barrow Neurological Institute, Nested as collaborator) is not yet recruiting. Whether it works in people has not been established unless a trial below reports it.
A non-degrading, fully brain-penetrant pan-RAF/MEK molecular glue that holds RAF and MEK (MEK1/2) together, hitting several parts of the RAS/MAPK pathway at once. Connects to MEK1/2.
1.NST-628 binds MEK1/2 with one end and an E3 ubiquitin ligase with the other.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"NST-628" OR ABSTRACT:"NST-628") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about NST-628, not a curated reading list.
Shares Melanoma, Metastatic cancer (cancer that has spread), Non-small-cell lung cancer and the tag pipeline.
Shares Brain and spinal cord tumours (all types), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Brain and spinal cord tumours (all types), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Melanoma, Metastatic cancer (cancer that has spread), Non-small-cell lung cancer and the tag pipeline.
Shares Melanoma, Metastatic cancer (cancer that has spread), Non-small-cell lung cancer and the tag pipeline.
Shares Melanoma, Metastatic cancer (cancer that has spread), Non-small-cell lung cancer and the tag pipeline.
Shares Melanoma, Non-small-cell lung cancer and the tag pipeline.
Shares MEK1/2, Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/